Evidence map›Paper›PMID 35961378›Full record

ArticleGastroenterology2022

Promise and Perils of Blood-based Signatures for Detecting Early-Onset Colorectal Cancer.

Siddharth Singh, Samir Gupta

Abstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Gastroenterology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Siddharth SinghDivision of Gastroenterology and, Division of Biomedical Informatics, Department of Medicine, University of California at San Diego, La Jolla, California. Electronic address: sis040@ucsd.edu.
Samir GuptaDivision of Gastroenterology, Department of Medicine, University of California at San Diego, La Jolla, California; Jennifer Moreno Veterans Affairs Medical Center, San Diego, California; Moores Cancer Center, University of California at San Diego, La Jolla, California.

Funding

Post-polypectomy Surveillance for Reducing Colon Cancer Incidence and MortalityR37CA222866 · NCI · VETERANS MEDICAL RESEARCH FDN/SAN DIEGO · PI GUPTA, SAMIR · 2018 to 2023
$3.3M
Comparative Risks and Benefits of Pharmacological Therapies for Older Patients with Inflammatory Bowel DiseasesK23DK117058 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SINGH, SIDDHARTH · 2018 to 2022
$971k
Predicting Short- and Long-term Risk of Serious Infections in Older Patients with Inflammatory Bowel DiseasesR03DK129631 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SINGH, SIDDHARTH · 2021 to 2022
$203k
NCI NIH HHS R37 CA222866NIDDK NIH HHS K23 DK117058NIDDK NIH HHS R03 DK129631
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Colorectal NeoplasmsHumans

Identifiers

PMID35961378
PMCPMC9613534

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.